ProMed Pharma Announces Agreement with Undisclosed Partner for Dedicated Manufacturing Suite at New Niagara Ln Facility
Agreement further validates business model and expansion plans PLYMOUTH, MN, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- ProMed Pharma, a leading contract development and manufacturing organization (CDMO) specializing in long-acting injectable …